静脉血栓栓塞症肥胖悖论的靶向蛋白质组学研究
基于693例VTE患者的前瞻性队列,采用靶向蛋白质组学检测444种蛋白,识别出11种与体重相关的蛋白特征,但该特征未显著介导肥胖悖论;瘦素与复发VTE或死亡呈负相关,且该关联受瘦素抵抗标志物修饰。
要点
- 11蛋白特征与体重相关,但未显著介导VTE肥胖悖论。
- 瘦素每增加1个标准差,复发VTE或死亡风险降低(aHR 0.66,95%CI 0.46-0.94)。
核心结论
- 11蛋白特征未显著介导VTE肥胖悖论,但瘦素与复发VTE或死亡呈负相关且受瘦素抵抗标志物修饰。
研究设计与样本
- 前瞻性队列研究,纳入693例VTE患者,急性期和12个月随访时采样,靶向蛋白质组学相对定量444种蛋白。
主要发现
- 识别出11蛋白特征(CLEC4C、FABP4、FLT3LG、IL-17C、LEP、LYVE1、MASP1、ST2、THBS2、THBS4、TSLP)与体重相关。
- 瘦素每增加1个标准差,复发VTE或死亡的调整HR为0.66(95%CI 0.46-0.94)。
临床怎么用
- 瘦素水平可能有助于识别VTE后复发或死亡风险较低的患者,但需考虑瘦素抵抗状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The obesity paradox, the controversial finding that obesity promotes disease development but protects against sequelae in patients, has been observed in venous thromboembolism (VTE). The aim of this investigation was to identify a body mass-related proteomic signature in VTE patients and to evaluate whether this signature mediates the obesity paradox in VTE patients. Data from the Genotyping and Molecular Phenotyping in Venous ThromboEmbolism Project, a prospective cohort study of 693 VTE patients, were analyzed. A combined end point of recurrent VTE or all-cause death was used. Relative quantification of 444 proteins was performed using high-throughput targeted proteomics technology. Measurements were performed in samples collected during the acute VTE event and at 12-month follow-up. An 11-protein signature (CLEC4C, FABP4, FLT3LG, IL-17C, LEP, LYVE1, MASP1, ST2, THBS2, THBS4, TSLP) for body mass in VTE patients was identified. The signature did not significantly mediate the obesity paradox (change in hazard ratio [HR]: 0.04; likelihood ratio test of nested models = 7.7; P = .74), but its main constituent protein, leptin, was inversely associated with recurrent VTE or death (adjusted HR [95% confidence interval] per standard deviation increase: 0.66 [0.46-0.94]). This relationship was significantly (P = .007) modified by markers of leptin resistance (ie, high body mass index and high circulating matrix metalloproteinase-2 levels). Although the signature did not substantially explain the obesity paradox, leptin appears to be protective against disease recurrence and death in VTE patients. This protective effect was abrogated under conditions of leptin resistance and hence was unrelated to the obesity paradox.
引用
- Ten Cate V, Koeck T, Prochaska J, et al. A targeted proteomics investigation of the obesity paradox in venous thromboembolism. Blood Adv. 2021. PMID: 34309635. doi:10.1182/bloodadvances.2020003800
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。